103 related articles for article (PubMed ID: 23834054)
21. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
Spector D; Shikora S
Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
[TBL] [Abstract][Full Text] [Related]
22. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
23. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
[TBL] [Abstract][Full Text] [Related]
24. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis.
Penhoat A; Mutel E; Amigo-Correig M; Pillot B; Stefanutti A; Rajas F; Mithieux G
Physiol Behav; 2011 Nov; 105(1):89-93. PubMed ID: 21402089
[TBL] [Abstract][Full Text] [Related]
25. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.
Kaska L; Sledzinski T; Chomiczewska A; Dettlaff-Pokora A; Swierczynski J
World J Gastroenterol; 2016 Oct; 22(39):8698-8719. PubMed ID: 27818587
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
[TBL] [Abstract][Full Text] [Related]
28. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.
Park S; Kim DS; Kwon DY; Yang HJ
J Neuroendocrinol; 2011 Aug; 23(8):687-98. PubMed ID: 21599766
[TBL] [Abstract][Full Text] [Related]
29. Insulin's direct effects on the liver dominate the control of hepatic glucose production.
Edgerton DS; Lautz M; Scott M; Everett CA; Stettler KM; Neal DW; Chu CA; Cherrington AD
J Clin Invest; 2006 Feb; 116(2):521-7. PubMed ID: 16453026
[TBL] [Abstract][Full Text] [Related]
30. [Intestinal gluconeogenesis: an insulin-mimetic function].
Mithieux G
Biol Aujourdhui; 2022; 216(1-2):37-39. PubMed ID: 35876519
[TBL] [Abstract][Full Text] [Related]
31. Insulin's effect on the liver: "direct or indirect?" continues to be the question.
Girard J
J Clin Invest; 2006 Feb; 116(2):302-4. PubMed ID: 16453016
[TBL] [Abstract][Full Text] [Related]
32. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
33. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
34. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
35. The role of insulin at brain-liver axis in the control of glucose production.
Ribeiro IMR; Antunes VR
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G538-G543. PubMed ID: 29878846
[TBL] [Abstract][Full Text] [Related]
36. Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis.
Patel RT; Shukla AP; Ahn SM; Moreira M; Rubino F
Obesity (Silver Spring); 2014 Jan; 22(1):159-69. PubMed ID: 23512969
[TBL] [Abstract][Full Text] [Related]
37. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
38. The selfish brain: competition for energy resources.
Fehm HL; Kern W; Peters A
Prog Brain Res; 2006; 153():129-40. PubMed ID: 16876572
[TBL] [Abstract][Full Text] [Related]
39. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
Tappy L
Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
[TBL] [Abstract][Full Text] [Related]
40. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
